In this respect, miR-192 downregulation in MPM is similar to that observed for colorectal [28–30] and childhood renal cancer [31], and lower miR-193a-3p reflects findings in oral squamous cell carcinoma [32], acute myeloid leukemia [33], lung cancer [17, 34] and BRAF-mutated melanoma [35]. This evidence concerns the gene BRAF and lung cancer.